ACQUISITION OF BENEFICIAL OWNERSHIP

Company

KalVista Pharmaceuticals, Inc.

Filed

December 30, 2021

Accession Number

0001387131-21-012403

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →